Head-to-head · WeighScore
Curex vs Tyde Wellness
By GLP-1 ScorecardUpdated
Score comparison
Tyde Wellness has the higher recorded score — 79.8/100 to 63.4/100.
Tyde Wellness grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Tyde advertises compounded GLP-1 injections with online clinician review and follow-up support.
Before you choose
Before comparing the headline prices, the Curex review and the Tyde Wellness review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.
If neither one fits, CoreAge Rx vs Curex and Defy Medical vs Tyde Wellness compare each of them with another graded program, and the list of alternatives to Curex ranks the programs closest to Curex on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
Of the sellers that pay us a commission, the Collective review covers one graded close to these two, at 71.6/100. That relationship never changes a grade, and the review lists what we could not verify.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Curex | Tyde Wellness |
|---|---|---|
| WeighScore | 63.4/100 | 79.8/100 |
| Grade | C | C+ |
| Site position | #276 | #39 |
| Semaglutide | First month from $49; renewal unverified | $88 starting price (compounded injection; billing interval unconfirmed) |
| Tirzepatide | First month from $149; renewal unverified | $125 starting price (compounded injection; billing interval unconfirmed) |
| Coverage | Confirm GLP-1 eligibility for your state | All 50 states |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Yes | Yes |
FDAWarning letter issued to Curex in September 2025. See the FDA warning-letter database.
Strengths
- Publishes medication-specific first-month starting prices
- GLP-1 terms describe how to stop the next order
What to consider
- Selected first and renewal charges need confirmation
- Landing page refund language and consultation-fee clause need clarification
- Unused prepaid months are not prorated under the terms
Strengths
- Advertises a free consultation
- Publishes membership cancellation instructions
What to consider
- Headline prices do not specify the billing interval
- Refunds after renewal are discretionary under membership terms
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.